Dr. Friedes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
Philadelphia, PA 19146
Education & Training
- University of Pennsylvania Health SystemResidency, Radiation Oncology, 2021 - 2026
- University of Pennsylvania Health SystemInternship, Preliminary Year, 2021 - 2022
- University of Central Florida College of MedicineClass of 2021, MD
Certifications & Licensure
- PA State Medical License 2021 - Present
Publications & Presentations
PubMed
- Acute hospitalizations after proton therapy versus intensity-modulated radiotherapy for locally advanced non-small cell lung cancer in the durvalumab era.Michelle Iocolano, Nikhil Yegya-Raman, Cole Friedes, Xingmei Wang, Timothy Kegelman
Cancer. 2024-06-01 - 2 citationsPhase 2 Trial of Consolidation Pembrolizumab After Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung Cancer.Nikhil Yegya-Raman, Abigail T Berman, Christine A Ciunci, Cole Friedes, Eva Berlin
International Journal of Radiation Oncology, Biology, Physics. 2024-05-01 - 1 citationsPlunging Into the PACIFIC: Outcomes of Patients With Unresectable KRAS-Mutated Non-Small Cell Lung Cancer Following Definitive Chemoradiation and Durvalumab Consolidat...Adam Barsouk, Cole Friedes, Michelle Iocolano, Abigail Doucette, Roger B Cohen
Clinical Lung Cancer. 2024-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: